Moors & Cabot Inc. Buys 1,501 Shares of Clorox Co (NYSE:CLX)

Moors & Cabot Inc. raised its stake in Clorox Co (NYSE:CLX) by 78.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,408 shares of the company’s stock after acquiring an additional 1,501 shares during the quarter. Moors & Cabot Inc.’s holdings in Clorox were worth $516,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of CLX. Tower View Investment Management & Research LLC raised its holdings in Clorox by 19.4% in the 2nd quarter. Tower View Investment Management & Research LLC now owns 387 shares of the company’s stock valued at $59,000 after buying an additional 63 shares during the last quarter. World Asset Management Inc raised its holdings in Clorox by 0.7% in the 2nd quarter. World Asset Management Inc now owns 9,872 shares of the company’s stock valued at $1,512,000 after buying an additional 65 shares during the last quarter. Arrow Financial Corp raised its holdings in Clorox by 9.2% in the 2nd quarter. Arrow Financial Corp now owns 892 shares of the company’s stock valued at $137,000 after buying an additional 75 shares during the last quarter. Cypress Capital Group raised its holdings in Clorox by 1.8% in the 2nd quarter. Cypress Capital Group now owns 4,312 shares of the company’s stock valued at $660,000 after buying an additional 75 shares during the last quarter. Finally, 6 Meridian raised its holdings in Clorox by 2.6% in the 2nd quarter. 6 Meridian now owns 3,211 shares of the company’s stock valued at $492,000 after buying an additional 80 shares during the last quarter. 78.45% of the stock is owned by hedge funds and other institutional investors.

Clorox stock opened at $150.76 on Friday. The company has a debt-to-equity ratio of 4.09, a quick ratio of 0.55 and a current ratio of 0.91. Clorox Co has a 52-week low of $143.58 and a 52-week high of $167.70. The firm has a 50 day moving average price of $152.96 and a two-hundred day moving average price of $154.74. The firm has a market cap of $18.80 billion, a price-to-earnings ratio of 23.85, a PEG ratio of 5.01 and a beta of 0.40.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The firm had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.69 billion. During the same quarter last year, the business earned $1.66 EPS. The company’s revenue was down 3.8% compared to the same quarter last year. As a group, equities research analysts predict that Clorox Co will post 6.18 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 30th will be issued a dividend of $1.06 per share. The ex-dividend date is Tuesday, October 29th. This represents a $4.24 annualized dividend and a yield of 2.81%. Clorox’s payout ratio is 67.09%.

In other Clorox news, SVP Michael R. Costello sold 6,997 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the completion of the transaction, the senior vice president now owns 29,016 shares in the company, valued at approximately $4,716,840.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Diego J. Barral sold 1,987 shares of the firm’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $157.59, for a total transaction of $313,131.33. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,609 shares of company stock valued at $2,497,443. Company insiders own 1.14% of the company’s stock.

A number of brokerages recently issued reports on CLX. Credit Suisse Group dropped their price objective on shares of Clorox from $172.00 to $168.00 and set an “outperform” rating for the company in a report on Thursday, October 3rd. Bank of America dropped their price objective on shares of Clorox from $165.00 to $160.00 and set a “neutral” rating for the company in a report on Thursday, October 3rd. Royal Bank of Canada raised their price objective on shares of Clorox to $161.00 and gave the company a “sector perform” rating in a report on Friday, August 2nd. Deutsche Bank dropped their price objective on shares of Clorox from $151.00 to $145.00 and set a “hold” rating for the company in a report on Thursday, October 3rd. Finally, UBS Group dropped their price objective on shares of Clorox from $128.00 to $125.00 and set a “sell” rating for the company in a report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $152.25.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: Why is total return important?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.